FDA Awards Absorption Systems Phase II SBIR Grant for CellPort Technologies(TM)
11/3/2009 8:40:37 AM
EXTON, Pa.--(BUSINESS WIRE)--Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company’s CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins. CellPort Technologies will become a key component of what is referred to as “Translational Medicine,” the process of translating the results from in vitro assays in model systems into human outcomes in the clinic.
comments powered by